These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9376593)
1. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Los M; Herr I; Friesen C; Fulda S; Schulze-Osthoff K; Debatin KM Blood; 1997 Oct; 90(8):3118-29. PubMed ID: 9376593 [TBL] [Abstract][Full Text] [Related]
2. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Fulda S; Friesen C; Los M; Scaffidi C; Mier W; Benedict M; Nuñez G; Krammer PH; Peter ME; Debatin KM Cancer Res; 1997 Nov; 57(21):4956-64. PubMed ID: 9354463 [TBL] [Abstract][Full Text] [Related]
3. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Fulda S; Los M; Friesen C; Debatin KM Int J Cancer; 1998 Mar; 76(1):105-14. PubMed ID: 9533769 [TBL] [Abstract][Full Text] [Related]
4. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Los M; Van de Craen M; Penning LC; Schenk H; Westendorp M; Baeuerle PA; Dröge W; Krammer PH; Fiers W; Schulze-Osthoff K Nature; 1995 May; 375(6526):81-3. PubMed ID: 7536901 [TBL] [Abstract][Full Text] [Related]
5. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Srinivasula SM; Ahmad M; Fernandes-Alnemri T; Litwack G; Alnemri ES Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14486-91. PubMed ID: 8962078 [TBL] [Abstract][Full Text] [Related]
6. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794 [TBL] [Abstract][Full Text] [Related]
7. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. Muzio M; Salvesen GS; Dixit VM J Biol Chem; 1997 Jan; 272(5):2952-6. PubMed ID: 9006941 [TBL] [Abstract][Full Text] [Related]
8. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. Cryns VL; Bergeron L; Zhu H; Li H; Yuan J J Biol Chem; 1996 Dec; 271(49):31277-82. PubMed ID: 8940132 [TBL] [Abstract][Full Text] [Related]
9. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S; Meyer E; Debatin KM Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673 [TBL] [Abstract][Full Text] [Related]
10. Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors. Armstrong RC; Aja T; Xiang J; Gaur S; Krebs JF; Hoang K; Bai X; Korsmeyer SJ; Karanewsky DS; Fritz LC; Tomaselli KJ J Biol Chem; 1996 Jul; 271(28):16850-5. PubMed ID: 8663439 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Antoku K; Liu Z; Johnson DE Leukemia; 1997 Oct; 11(10):1665-72. PubMed ID: 9324287 [TBL] [Abstract][Full Text] [Related]
12. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Jeremias I; Herr I; Boehler T; Debatin KM Eur J Immunol; 1998 Jan; 28(1):143-52. PubMed ID: 9485194 [TBL] [Abstract][Full Text] [Related]
13. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102 [TBL] [Abstract][Full Text] [Related]
14. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Chlichlia K; Peter ME; Rocha M; Scaffidi C; Bucur M; Krammer PH; Schirrmacher V; Umansky V Blood; 1998 Jun; 91(11):4311-20. PubMed ID: 9596680 [TBL] [Abstract][Full Text] [Related]
15. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. Seimiya H; Mashima T; Toho M; Tsuruo T J Biol Chem; 1997 Feb; 272(7):4631-6. PubMed ID: 9020192 [TBL] [Abstract][Full Text] [Related]
16. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis. Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869 [TBL] [Abstract][Full Text] [Related]
17. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing. Wagenknecht B; Schulz JB; Gulbins E; Weller M Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695 [TBL] [Abstract][Full Text] [Related]
18. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383 [TBL] [Abstract][Full Text] [Related]
19. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521 [TBL] [Abstract][Full Text] [Related]
20. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. Martin SJ; Finucane DM; Amarante-Mendes GP; O'Brien GA; Green DR J Biol Chem; 1996 Nov; 271(46):28753-6. PubMed ID: 8910516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]